Two cell therapy centres to be set up in region

31 May 2010

US-based Bioheart has unveiled plans to set up two centres of excellence in the region to provide its cell therapy procedures to patients of congestive heart failure and peripheral arterial disease. The company has commenced work in Jordan on its Regen trial, a phase I clinical trial to test genetically modified MyoCell in patients suffering from congestive heart failure. The first patient is expected to receive treatment in July. The firm also has plans for establishing a cell manufacturing facility in Jordan as well.

A MEED Subscription...

Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.

Get Notifications